Literature DB >> 2874114

Virulence properties of Escherichia coli strains in patients with chronic pyelonephritis.

R Fünfstück, H Tschäpe, G Stein, H Kunath, M Bergner, G Wessel.   

Abstract

In 50 Escherichia coli strains obtained from the bladder puncture urine of patients with chronic pyelonephritis, determinations of virulence properties were performed. All of the E. coli strains isolated from 26 acute episodes of pyelonephritis were found in the smooth form. 30% possessed K 1 antigen, 77% showed the ability to form hemolysin and 30% produced colicin V (aerobactin). Fimbriae (detected by mannose-resistant hemagglutination) were registered in 81%, and plasmids ranging between 50 and 70 Md were demonstrated in 70% of the bacteria. In contrast to this, only 70% of the E. coli strains isolated from 24 patients at an inactive stage of pyelonephritis were found in the smooth form; 10% of these encoded K 1 antigen, 20% hemolysin and 10% colicin V. Plasmids in the range 50 to 70 Md could be found in 30%. On the basis of multivariate analysis of variance and discriminant analysis, it was confirmed that uropathogenic strains possess several virulence properties, mannose-resistant hemagglutination being of particular importance.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2874114     DOI: 10.1007/bf01643482

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  33 in total

1.  [Comparison of the frequency of the O-antigens of E. coli strains isolated from urine in Rostock and Moscow].

Authors:  G Naumann; W Nimmich; E Budde; I W Golubewa; B S Kisselowa; N I Andronowa; I N Ulisko
Journal:  Z Gesamte Hyg       Date:  1979-08

2.  K antigens of Escherichia coli and renal involvement in urinary-tract infections.

Authors:  A A Glynn; W Brumfitt; C J Howard
Journal:  Lancet       Date:  1971-03-13       Impact factor: 79.321

3.  [Long-term follow-up of children with urinary tract infection: bacterial spectrum, E. coli-serotypes 0, relapse, and reinfection (author's transl)].

Authors:  W Sietzen; M Kienitz; H Knothe
Journal:  Dtsch Med Wochenschr       Date:  1975-12-26       Impact factor: 0.628

4.  [Change of pathogeus and pathogen persistence in chronic urinary tract infections in childhood. E. coli-O-serotypes in follow-up].

Authors:  W Sietzen; F Daschner
Journal:  MMW Munch Med Wochenschr       Date:  1976-11-05

5.  alpha-Haemolysin: an additive virulence factor in Escherichia coli.

Authors:  L Emödy; T Pál; N V Safonova; B Kuch; N K Golutva
Journal:  Acta Microbiol Acad Sci Hung       Date:  1980

6.  Synthesis and secretion of hemolysin by Escherichia coli.

Authors:  W Springer; W Goebel
Journal:  J Bacteriol       Date:  1980-10       Impact factor: 3.490

7.  Iron-suppressible production of hydroxamate by Escherichia coli isolates.

Authors:  S J Stuart; K T Greenwood; R K Luke
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

8.  Simple agarose gel electrophoretic method for the identification and characterization of plasmid deoxyribonucleic acid.

Authors:  J A Meyers; D Sanchez; L P Elwell; S Falkow
Journal:  J Bacteriol       Date:  1976-09       Impact factor: 3.490

9.  Some characteristics of Escherichia coli strains isolated from extraintestinal infections of humans.

Authors:  B H Minshew; J Jorgensen; M Swanstrum; G A Grootes-Reuvecamp; S Falkow
Journal:  J Infect Dis       Date:  1978-05       Impact factor: 5.226

10.  The association of the O18, K1 and H7 antigens and the Co1V plasmid of a strain of Escherichia coli with its virulence and immunogenicity.

Authors:  H W Smith; M B Huggins
Journal:  J Gen Microbiol       Date:  1980-12
View more
  13 in total

1.  Molecular characterization of the Escherichia coli asymptomatic bacteriuria strain 83972: the taming of a pathogen.

Authors:  Per Klemm; Viktoria Roos; Glen C Ulett; Catharina Svanborg; Mark A Schembri
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 2.  Mellowing out: adaptation to commensalism by Escherichia coli asymptomatic bacteriuria strain 83972.

Authors:  Per Klemm; Viktoria Hancock; Mark A Schembri
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

3.  Leukotriene and hydroxyeicosatetraenoic acid generation elicited by low doses of Escherichia coli hemolysin in rabbit lungs.

Authors:  F Grimminger; D Walmrath; R G Birkemeyer; S Bhakdi; W Seeger
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

4.  Comparison of asymptomatic bacteriuria Escherichia coli isolates from healthy individuals versus those from hospital patients shows that long-term bladder colonization selects for attenuated virulence phenotypes.

Authors:  Ellaine Salvador; Florian Wagenlehner; Christian-Daniel Köhler; Alexander Mellmann; Jörg Hacker; Catharina Svanborg; Ulrich Dobrindt
Journal:  Infect Immun       Date:  2011-11-21       Impact factor: 3.441

5.  Thromboxane-mediated hypertension and vascular leakage evoked by low doses of Escherichia coli hemolysin in rabbit lungs.

Authors:  W Seeger; H Walter; N Suttorp; M Muhly; S Bhakdi
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

Review 6.  Virulence factors in Escherichia coli urinary tract infection.

Authors:  J R Johnson
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

7.  Escherichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils.

Authors:  F Grimminger; U Sibelius; S Bhakdi; N Suttorp; W Seeger
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Inflammatory lipid mediator generation elicited by viable hemolysin-forming Escherichia coli in lung vasculature.

Authors:  F Grimminger; M Thomas; R Obernitz; D Walmrath; S Bhakdi; W Seeger
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

9.  Endotoxin "priming" potentiates lung vascular abnormalities in response to Escherichia coli hemolysin: an example of synergism between endo- and exotoxin.

Authors:  D Walmrath; H A Ghofrani; S Rosseau; H Schütte; A Cramer; W Kaddus; F Grimminger; S Bhakdi; W Seeger
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  Pore-forming bacterial toxins potently induce release of nitric oxide in porcine endothelial cells.

Authors:  N Suttorp; M Fuhrmann; S Tannert-Otto; F Grimminger; S Bhadki
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.